Literature DB >> 15979765

Quantification of oxidized RNAs in Alzheimer's disease.

Xiu Shan1, Chien-Liang Glenn Lin.   

Abstract

Cytoplasmic RNA oxidation is a prominent feature of vulnerable neurons in the brains of Alzheimer's disease (AD) patients. We previously demonstrated that messenger RNAs (mRNA) are oxidized in AD brains. However, the magnitude of the mRNA oxidation is unclear. In the present study, we separated oxidized mRNAs from non-oxidized mRNAs by immunoprecipitation and then quantitatively analyzed both mRNA fractions. Surprisingly, 30-70% of the mRNAs isolated from AD frontal cortices were oxidized while the abundance of oxidized mRNAs was low in age-matched normal controls. Furthermore, we previously showed that some mRNA species are more susceptible to oxidative damage. Here, we quantified the degree of oxidation for individual mRNA species that were previously found to be oxidized in AD. Quantitative analysis revealed that the relative amounts of oxidized transcripts reach 50-70% for some mRNA species. These high abundances implicate the potential contribution of mRNA oxidation to the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979765     DOI: 10.1016/j.neurobiolaging.2005.03.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  50 in total

Review 1.  Oxidative damage to RNA in aging and neurodegenerative disorders.

Authors:  Akihiko Nunomura; Paula I Moreira; Rudy J Castellani; Hyoung-Gon Lee; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Neurotox Res       Date:  2012-06-06       Impact factor: 3.911

2.  The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Authors:  Akihiko Nunomura; Toshio Tamaoki; Nobutaka Motohashi; Masao Nakamura; Daniel W McKeel; Massimo Tabaton; Hyoung-Gon Lee; Mark A Smith; George Perry; Xiongwei Zhu
Journal:  J Neuropathol Exp Neurol       Date:  2012-03       Impact factor: 3.685

Review 3.  Redox proteomics and amyloid β-peptide: insights into Alzheimer disease.

Authors:  D Allan Butterfield; Debra Boyd-Kimball
Journal:  J Neurochem       Date:  2018-11-27       Impact factor: 5.372

4.  Altered 8-oxoguanine glycosylase in mild cognitive impairment and late-stage Alzheimer's disease brain.

Authors:  Changxing Shao; Shuling Xiong; Guo-Min Li; Liya Gu; Guogen Mao; William R Markesbery; Mark A Lovell
Journal:  Free Radic Biol Med       Date:  2008-06-11       Impact factor: 7.376

5.  An active role for the ribosome in determining the fate of oxidized mRNA.

Authors:  Carrie L Simms; Benjamin H Hudson; John W Mosior; Ali S Rangwala; Hani S Zaher
Journal:  Cell Rep       Date:  2014-11-13       Impact factor: 9.423

Review 6.  RNA oxidation and zinc in hepatic encephalopathy and hyperammonemia.

Authors:  Freimut Schliess; Boris Görg; Dieter Häussinger
Journal:  Metab Brain Dis       Date:  2009-01-16       Impact factor: 3.584

Review 7.  Markers of oxidant stress that are clinically relevant in aging and age-related disease.

Authors:  Kimberly D Jacob; Nicole Noren Hooten; Andrzej R Trzeciak; Michele K Evans
Journal:  Mech Ageing Dev       Date:  2013-02-18       Impact factor: 5.432

Review 8.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

9.  Sublethal RNA oxidation as a mechanism for neurodegenerative disease.

Authors:  Rudy J Castellani; Akihiko Nunomura; Raj K Rolston; Paula I Moreira; Atsushi Takeda; George Perry; Mark A Smith
Journal:  Int J Mol Sci       Date:  2008-05-20       Impact factor: 6.208

10.  MicroRNA expression in Alzheimer blood mononuclear cells.

Authors:  Hyman M Schipper; Olivier C Maes; Howard M Chertkow; Eugenia Wang
Journal:  Gene Regul Syst Bio       Date:  2007-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.